Descriptor English: | Prostaglandin H2 | ||||||
Descriptor Spanish: |
Prostaglandina H2
| ||||||
Descriptor Portuguese: | Prostaglandina H2 | ||||||
Descriptor French: | Prostaglandine H2 | ||||||
Entry term(s): |
PGH(2) PGH2 |
||||||
Tree number(s): |
D01.248.497.158.685.750.744.650.500 D01.339.431.374.744.650.500 D01.650.550.750.700.650.500 D02.389.593.374.744.650.500 D10.251.355.255.550.025.650.500 D23.469.050.175.725.025.650.500 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D044262 | ||||||
Scope note: | A cyclic endoperoxide intermediate produced by the action of CYCLOOXYGENASE on ARACHIDONIC ACID. It is further converted by a series of specific enzymes to the series 2 prostaglandins. |
||||||
Annotation: | /analogs: coord with PROSTAGLANDIN ENDOPEROXIDES, SYNTHETIC if pertinent |
||||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis DF deficiency EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PH physiology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Registry Number: | 42935-17-1 | ||||||
CAS Type 1 Name: | Prosta-5,13-dien-1-oic acid, 9,11-epidioxy-15-hydroxy-, (5Z,9alpha,11alpha,13E,15S)- | ||||||
Previous Indexing: |
Prostaglandin Endoperoxides, Synthetic (1986-1992) Prostaglandins H (1993-2003) |
||||||
Public MeSH Note: | 2004; PROSTAGLANDIN H2 was indexed under PROSTAGLANDINS H 1993-2003 & PROSTAGLANDIN ENDOPEROXIDES, SYNTHETIC 1986-1992 |
||||||
History Note: | 2004; use PROSTAGLANDIN H2 (NM) 1980-2003 |
||||||
DeCS ID: | 38230 | ||||||
Unique ID: | D044262 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 2004/01/01 | ||||||
Date of Entry: | 2003/07/09 | ||||||
Revision Date: | 2015/06/08 |
-
-
CHEMICALS AND DRUGS
Inorganic Chemicals [D01]Inorganic Chemicals -
CHEMICALS AND DRUGS
Inorganic Chemicals [D01]Inorganic Chemicals -
CHEMICALS AND DRUGS
Inorganic Chemicals [D01]Inorganic Chemicals -
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Lipids [D10]Lipids -
CHEMICALS AND DRUGS
Biological Factors [D23]Biological Factors
|
Prostaglandin H2
- Preferred
Concept UI |
M0086362 |
Scope note | A cyclic endoperoxide intermediate produced by the action of CYCLOOXYGENASE on ARACHIDONIC ACID. It is further converted by a series of specific enzymes to the series 2 prostaglandins. |
Preferred term | Prostaglandin H2 |
Entry term(s) |
PGH(2) PGH2 |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey